Biomedical Engineering Reference
In-Depth Information
be considered. Thus, equation (11.62) can be rewritten as
2 c j
∂r 2
φ f ∂c j
∂t
∂c j
∂r
2
+ 1 − φ f
∂c ji
+ 1
r
∂t − φ f D j
i =1
+ φ f v r
∂c j
∂r
2
∂c ji
∂r
+ 1
φ f v r
κ r ∂p
∂r
=0 ,j =1 , 2
(11.63)
i =1
The average free and bound (complexed) IGF uptake ratio become
r 0 2 πrc i dr
1
c i 0
R f
Free IGF uptake ratio :
ui =
r 0
0
(11.64)
2 πrdr
r 0 2 πrc ij dr
2
1
c i 0
R s
Bound IGF uptake ratio :
ui =
r 0
0
(11.65)
2 πrdr
j =1
11.4.2.6
Free Diffusion with Competitor
Experiments showed a significant increase in the free IGF-I level in human
synovial fluid in both OA and rheumatoid arthritis patients in comparison
with normal cartilage (e.g., increasing from 20 to 80 ng/mL), but no change
in the level of IGF-II [62]. Shown in Figure 11.14 are results of a “math-
ematical experiment” to understand the bioavailability of free IGF-I under
various cartilage conditions. The IGF-I concentration ( c f
10 ) in the solute bath
(synovial fluid) is varied to explore the possible IGF-I transport behavior for
“OA” (i.e., “diseased”) conditions. The results show that the rate of free IGF-I
uptake is relatively high in the diseased condition (Figure 11.14[a]), whereas
a decrease of bound IGF-I uptake is observed.
11.4.2.7
Growth Factor Transport with Competitor and Cyclic
Deformation
In cartilage synovial fluid, free IGF-I concentration is low (around 20 ng/mL)
in comparison to that of free IGF-II (around 200 ng/mL) [62]. In previous sec-
tions it was shown that cyclic loading enhances IGF-I transport. However, the
combination of competitive binding and cyclic loading might further modify
the transport behavior of IGF-I. Figure 11.15 shows the percent increased in
time-dependent free and bound IGF-I uptake in normal cartilage condition,
in the absence (i.e., c f
10 = 20 ng/mL, c f
20 = 0 ng/mL) or in the presence of
IGF-II competition (i.e., c f
10 = 20 ng/mL, c f
20 = 200 ng/mL), after 5 h 0.1 Hz
at 6% strain cyclic deformation. The results indicate that cyclic loading still
enhances IGF-I uptake in both cases; however, the enhancement is reduced
when a competitor for binding sites is introduced. The competitor effectively
 
Search WWH ::




Custom Search